Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Oct 1;45(4):259-265.
doi: 10.1097/NPT.0000000000000362.

Are Mobile Persons With Parkinson Disease Necessarily More Active?

Affiliations
Randomized Controlled Trial

Are Mobile Persons With Parkinson Disease Necessarily More Active?

Jenna A Zajac et al. J Neurol Phys Ther. .

Abstract

Background and purpose: Walking activity in persons with Parkinson disease (PD) is important for preventing functional decline. The contribution of walking activity to home and community mobility in PD is poorly understood.

Methods: Cross-sectional baseline data (N = 69) were analyzed from a randomized controlled PD trial. The Life-Space Assessment (LSA) quantified the extent, frequency, and independence across 5 expanding levels of home and community mobility, producing individual subscores and a total score. Two additional summed scores were used to represent mobility within (Levels 1-3) and beyond (Levels 4-5) neighborhood limits. An accelerometer measured walking activity for 7 days. Regression and correlation analyses evaluated relationships between daily steps and mobility scores. Mann-Whitney U tests secondarily compared differences in mobility scores between the active and sedentary groups.

Results: Walking activity contributed significantly to the summed Level 1-3 score (β = 0.001, P = 0.004) but not to the summed Level 4-5 (β = 0.001, P = 0.33) or total (β = 0.002, P = 0.07) scores. Walking activity was significantly related to Level 1 (ρ = 0.336, P = 0.005), Level 2 (ρ = 0.307, P = 0.010), and Level 3 (ρ = 0.314, P = 0.009) subscores. Only the summed Level 1-3 score (P = 0.030) was significantly different between the active and sedentary groups.

Discussion and conclusions: Persons with PD who demonstrated greater mobility beyond the neighborhood were not necessarily more active; walking activity contributed more so to home and neighborhood mobility. Compared with LSA total score, the Level 1-3 summed score may be a more useful participation-level measure for assessing the impact of changes in walking activity.Video Abstract available for more insights from the authors (see the Video, Supplemental Digital Content 1 available at: http://links.lww.com/JNPT/A349).

Trial registration: ClinicalTrials.gov NCT03517371.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Model representing individual LSA levels within neighborhood limits (white) and beyond neighborhood limits (gray). The model portrays walking activity as more prevalent in LSA levels 1-3 (A) and passive mobility as more prevalent in LSA levels 4-5 (B).
Figure 2.
Figure 2.
Between-group differences in individual level scores (LSA Levels 1-5) based on walking activity (sedentary vs active). The x-axis depicts the five individual life-space levels as follows: Level 1 = inside the home; Level 2 = immediately outside the home (e.g., yard, driveway); Level 3 = neighborhood; Level 4 = town; Level 5 = beyond town. The y-axis depicts the percentage of participants that scored the maximum score for each individual life-space level. *p<.05. The between-group difference in mobility is most pronounced in the neighborhood environment (Level 3).

References

    1. Skantz H, Rantanen T, Palmberg L, Rantalainen T, Aartolahti E, Portegijs E et al.Outdoor mobility and use of adaptive or maladaptive walking modifications among older people. The Gerontological Society of America 2020;75(4):806–812. - PubMed
    1. Rantanen T Promoting mobility in older people. Journal of Preventative Medicine & Public Health 2013;46:S50–S54. - PMC - PubMed
    1. Ellis TD, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Thackeray A, Thiese MS, Dibble LE. Identifying clinical measures that most accurately reflect the progression of disability in Parkinson disease. Parkinsonism Relat Disord 2016;25:65–71. - PubMed
    1. Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS et al.The evolution of disability in Parkinson disease. Movement Disorders. 2008;23(6):790–796. - PubMed
    1. Shulman LM. Understanding disability in Parkinson’s disease. Movement Disorders. 2010;25(1):131–135. - PubMed

Publication types

Associated data